SCHEMBL19081476

SCHEMBL19081476

c1ccc(-c2ccc3cc(-c4c5ccccc5c(-c5ccc6oc7cc8c(cc7c6c5)oc5cc6ccccc6cc58)c5ccccc45)ccc3c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.44
PLA2G2A P14555 3/20 0.43
PLA2G4A P47712 3/20 0.43
KDM4E B2RXH2 3/20 0.39
HPGD P15428 3/20 0.39
MAPT P10636 2/20 0.39
TSHR P16473 2/20 0.39
HSD17B10 Q99714 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
GLA P06280 2/20 0.39
HTT P42858 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
ESR1 P03372 5/20 0.39
ESR2 Q92731 5/20 0.39
CASP3 P42574 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
PLA2G10 O15496 1/20 0.38
ALDH1A1 P00352 2/20 0.38
ALOX15 P16050 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16067772 0.99 PGR (0.45) PGRPLA2G2APLA2G4AKDM4EHPGD
SCHEMBL17931966 0.96 ESR1 (0.43) PGRPLA2G2APLA2G4AKDM4EHPGD
SCHEMBL23109415 0.94 PGR (0.42) PGRPLA2G2APLA2G4AKDM4EHPGD
SCHEMBL22007442 0.94 PGR (0.44) PGRPLA2G2APLA2G4AKDM4EHPGD
SCHEMBL19081567 0.94 ESR1 (0.40) PGRPLA2G2APLA2G4AKDM4EHPGD
SCHEMBL25667898 0.94 PGR (0.44) PGRPLA2G2APLA2G4AKDM4EHPGD
SCHEMBL19081489 0.94 PLA2G2A (0.44) PGRPLA2G2APLA2G4AKDM4EHPGD
SCHEMBL24024567 0.93 PGR (0.41) PGRPLA2G2APLA2G4AKDM4EHPGD
SCHEMBL24024503 0.93 PGR (0.41) PGRPLA2G2APLA2G4AKDM4EHPGD
SCHEMBL21126843 0.93 PGR (0.41) PGRPLA2G2APLA2G4AKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 PGR 1721/4885PLA2G2A 4330/4885PLA2G4A 4338/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 PGR 1721/4885PLA2G2A 4330/4885PLA2G4A 4338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.